Edilberto Amorim, MD, of the MGH Clinical Data Animation Center and Neurocritical Care Division, has received the 2019 Society of Critical Care Medicine Weil Award. This award recognizes outstanding laboratory or clinical research in the field of critical care medicine. Amorim is investigating how computational analysis of clinical, neuroimaging and neurophysiology data might facilitate outcome prediction and management of patients with coma after cardiac arrest.
 
Alessandro Biffi, MD, of the Neurology Department, has received the 2019 Michael S. Pessin Stroke Leadership Prize from the American Academy of Neurology. This award recognizes emerging neurologists who have a strong interest in and have demonstrated a passion for learning and expanding the field of stroke research and have an active involvement in providing patients with the highest quality of compassionate care.
 
Branko Bojovic, MD, of MGH Plastic & Reconstructive Surgery, has received the National Gold Medal for Achievement in Medicine and Science in Belgrade, Serbia. Presented to Bojovic by the president of Serbia, this award honors those who have made remarkable achievements in an area of excellence that reflects well on the country and denotes a beneficial impact to the masses. Those awarded are chosen by a special nominating committee and then ultimately by the president.
 
Genevieve Boland, MD, PhD, director of the Melanoma Surgery Program and Surgical Oncology Research Labs, has received the 2018 Melanoma Research Foundation Breakthrough Consortium Young Investigator Research Team Award to Advance the Field of Translational Immuno-Oncology. The award helps identify and support the next generation of melanoma scientists and focuses on improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. Boland was honored – as the team’s lead principal investigator – along with Srinivas Saladi, PhD, of Mass Eye and Ear and David Liu, MD, of Dana Farber Cancer Center.
 
Andrew T. Chan, MD, MPH, chief of the Clinical and Translational Epidemiology Unit, has received the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research from the American Association for Cancer Research (AACR). The award recognizes worthy cancer researchers who have conducted highly meritorious laboratory, translational or clinical cancer research anywhere in the world. Chan is being recognized for his pioneering work on the molecular mechanisms of aspirin in both the prevention and treatment of colorectal cancer. His work has influenced current clinical guidelines for chemoprevention and led the field in recognizing and developing the concept of precision chemoprevention. 
 
Dan G. Duda, DMD, PhD, director of Translational Research in GI Radiation Oncology at MGH, has received an Impact Award from the Department of Defense Peer-Reviewed Cancer Research Program. The project will examine the role and biomarker value of HGF/MET axis in radiation-induced liver damage susceptibility in patients with hepatocellular carcinoma. This includes preclinical studies as well as studies integrated in a randomized phase III trial of proton therapy led by Theodore S. Hong, MD,director of GI Radiation Oncology at MGH. The studies are based on pilot data recently reported by the group in Nature Precision Oncology. If successful, this approach could developments that would be major advances for safely implementing personalized radiotherapy in unresectable liver cancers.
 
Greg Low, RPh, PhD, program director of the MGPO Pharmacy Quality and Utilization Program, has been appointed a member of the New England Comparative Effectiveness Public Advisory Council(CEPAC) by the Institute for Clinical and Economic Review. The New England CEPAC convenes three times each year at public meetings to review objective evidence reports and develop recommendations for how stakeholders can apply evidence to improve the quality and value of health care. The new members join the councils of regionally-based experts who represent a broad range of perspectives including medical ethics, patient advocacy and engagement, outcomes research, health economics, technology assessment and clinical practice.
 
The MGH Institute of Health Profession’s two graduate-level nursing programs received high marks in the U.S. News & World Report’s 2020 Best Graduate Schools list, released March 12. The Master of Science in Nursing program ranked 53rd in the country out of 252 master’s programs, its highest-ever ranking by the national publication. It is second in Greater Boston and Massachusetts, ahead of more than a dozen direct-entry advanced-practice nursing programs in New England. The Doctor of Nursing Practice (DNP) program, a post-professional online doctorate which is the nursing profession’s terminal clinical degree, is ranked 60th in the country out of 182 programs. It is second in Greater Boston and third in Massachusetts, ahead of several DNP programs in New England.
 
Paul Myoung, senior administrative director for Transplant Center and Division of Transplant Surgery, has been named a 2019 Thomas C. Dolan Executive Diversity Scholar by the American College of Healthcare Executives. This highly competitive program is designed as a once-in-a-career opportunity for promising mid- and senior-level careerists, committed to the health care management field. Since joining the MGH team in 2017, he has made significant positive impacts to the growing Transplant programs.
 
Patricia O’Malley, MD, medical director of the Pediatric Palliative Care Service, has received the inaugural Ilene Beal Courageous Provider Award. The award recognizes a pediatric provider who provides exceptional family-centered care in circumstances of serious childhood illness, and who demonstrates qualities of compassion, empathy and an ability to accompany families during difficult phases of the illness journey. The award committee cited O’Malley’s “dedication to seeing and treating the family unit with an eye to alleviating the physical and emotional pain, fear and isolation common to so many facing lifespan-limiting pediatric illness. The powerful combination of Pat O’Malley’s clinical acumen and sensitivity to the child’s and family’s needs promotes hope and courage, having a powerful impact under extraordinary, almost unthinkable, circumstances.” Pictured, from left: Blyth Taylor Lord, founder and executive director of Courageous Parents Network; O’Malley; Brian Potts, Ilene Beal Foundation trustee; Ron Kleinman, MD, chief of the Department of Pediatrics at MassGeneral Hospital for Children; and David Vaughn, Ilene Beal Foundation trustee.
 
Harry Orf, PhD, senior vice president for Research, was honored with an 8-Spoked Salute at a Boston Bruins home game for his military service. At select games throughout the 2018-19 Bruins season, a member or members of the U.S. armed forces – active duty, guard or reserve – receives the 8-Spoked Salute for their service to our country. Orf served in the military for 34 years, rising to the rank of full colonel. Following active duty tours in former Soviet Bloc countries in Europe and NATO Headquarters in Belgium, Orf was deployed to Iraq during Operation Iraqi Freedom, where he served with the 804th Medical Brigade as the senior nuclear medical officer in theater and was awarded the Bronze Star for his distinguished service. Orf also received two Meritorious Service Medals and, upon his retirement from the Army Medical Command in 2005, was awarded the Legion of Merit Medal.
 
David Scadden, MD, director of the Center for Regenerative Medicine, has received the Donald Metcalf Award from the International Society of Experimental Hematology. The award – established in 1999 recognizing Metcalf for his pioneering work on the control of blood cell formation – honors distinguished scientists who have made seminal contributions in the field of Hematology.
 
Lee H. Schwamm, MD, FAHA, FANA, executive vice chairman of the Neurology Department and director of the MGH Comprehensive Stroke Center and the MGH Center for TeleHealth, has been selected as incoming chair of the American Stroke Association Advisory Committee, effective July 1. Schwamm also has been appointed a member of the American Heart Association Board of Directors.
 
Mehmet Toner, PhD, a founding co-director of the MGH Center for Engineering in Medicine and the MGH BioMicroElectroMechanical Systems Center, has received the Vehbi Koc Award from the Vehbi Koc Foundation. One of the most prestigious awards in Turkey, it recognizes Toner for his lifetime scientific and educational achievements. Every year, the Vehbi Koc Foundation of Turkey awards those with the highest impact in their own fields which span politics, culture, health care, science and education. The foundation specifically recognized Toner’s long-standing work on the identification of circulating tumor cells in blood via microfluidic platforms.
 
Ana-Maria Vranceanu, PhD, director of the Integrated Brain Health Clinical and Research Program in the Department of Psychiatry, has been appointed a Fellow of the Society of Behavioral Medicine (SBM). Fellow status is a distinction conferred on full members in recognition of outstanding contributions to the advancement of the science and practice of behavioral medicine. Vranceanu also has received the SBM’s Distinguished Scientist in Complementary and Integrative Medicine Award.